Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 18/20 | 0.56 |
| ▸ | NPY1R | P25929 | 11/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.56 |
| ▸ | NPY2R | P49146 | 7/20 | 0.56 |
| ▸ | NMT2 | O60551 | 1/20 | 0.43 |
| ▸ | NMT1 | P30419 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29991238 | 0.98 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29569365 | 0.95 | NPY4R (0.49) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29808495 | 0.94 | NPY4R (0.51) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29967673 | 0.94 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29678407 | 0.93 | NPY4R (0.47) | NPY4RNPY1RNPY5RNPY2RNMT2 | |
| SCHEMBL29872588 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29666908 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30490411 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30903441 | 0.92 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30395232 | 0.92 | NPY4R (0.45) | NPY4RNPY1RNPY5RNPY2RNMT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250230218-A1 | PDL1 PEPTIDES FOR USE IN CANCER VACCINES | IO BIOTECH APS (DK) | 2025-07-17 | — | — | US | disclosed |
| US-12187782-B2 | PDL1 peptides for use in cancer vaccines | IO BIOTECH APS (DK) | 2025-01-07 | — | — | US | disclosed |
| US-20220372108-A1 | PDL1 PEPTIDES FOR USE IN CANCER VACCINES | IO BIOTECH APS (DK) | 2022-11-24 | — | — | US | disclosed |